Literature DB >> 30905593

[Which place of antiphosphatidylethanolamine antibodies research in seronegative antiphospholipid syndrome suspicion?]

P Billoir1, S Miranda2, J Abboud3, G Armengol2, H Levesque2, Y Benhamou2, V Le Cam Duchez4.   

Abstract

PURPOSE: Antiphospholipid syndrome (APS) is a clinico-biological syndrome, which associates vascular injury and persisting antiphospholipid antibodies (aPL). Patients with clinical symptoms of APS but without aPL are defined as "seronegative APS" (SNAPS). The aim of this study was to evaluate antiphosphatidylethanolamine antibody (aPE) investigation in patients with SNAPS suspicion.
METHODS: This retrospective study was conducted in patients with SNAPS suspicion. A homemade enzyme-linked immunosorbent assay (ELISA) was used to search for aPE. The results of this homemade method were compared with those from a global screening ELISA.
RESULTS: Two hundred twenty-eight patients with SNAPS suspicion were included. Among them, 58.3% had a thrombotic event. The homemade ELISA found positive persisting aPE in 23 patients (10%): 15 with a thrombotic event, 6 with obstetrical morbidity and 2 with a combined event. The global screening ELISA was positive in only 11 of these 23 patients (47.8%).
CONCLUSION: These results suggest the implication of aPE in SNAPS.
Copyright © 2018 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticorps antiphosphatidyléthanolamine; Antiphosphatidylethanolamine antibody; Antiphospholipid antibodies screening; Screening anticorps antiphospholipides; Seronegative antiphospholipid syndrome; Syndrome des antiphospholipides seronégatif; Thrombose; Thrombosis

Mesh:

Substances:

Year:  2019        PMID: 30905593     DOI: 10.1016/j.revmed.2018.11.013

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  1 in total

Review 1.  Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management.

Authors:  Pasquale Pignatelli; Evaristo Ettorre; Danilo Menichelli; Arianna Pani; Francesco Violi; Daniele Pastori
Journal:  Haematologica       Date:  2020-01-30       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.